Serotonin plays an important role in mood regulation, but the involvement of serotonin pathway genes in the development of bipolar I disorder (BP-I), a mood disorder, is not clear. We selected 21 singlenucleotide polymorphisms (SNPs) within the HTR2A gene, 8 within the SLC6A4 gene and 23 within the TPH2 gene for genotyping using the GoldenGate genotyping assay. A total of 375 patients with BP-I and 475 normal controls were recruited. Two out of 21 SNPs (rs1475196 and rs9567747) in the HTR2A gene and 1/23 SNPs (rs17110566) in the TPH2 gene were significantly associated with BP-I, both genotype-wise and allele-wise. Furthermore, a specific haplotype in the HTR2A gene showed a signifi cant association with BP-I. Our results indicate that the HTR2A and TPH2 genes in the serotonin pathway play important roles in susceptibility to BP-I.
INTRODUCTION
People with bipolar affective disorder (BPD) experience severe, disruptive mood swings. At some points in their life, patients with BPD may experience abnormally elevated mood, energy, and activity to a degree that interferes with the functions of ordinary life. At other times, they may endure the opposite state with abnormally low mood, energy, and activity [1] . The lifetime prevalence of BPD is 0.3% to 1.5% with a similar ratio in men and women [2] .
Despite the high prevalence together with psychosocial impairment and a high risk of suicide in patients with BPD, the pathogenesis of the disorder is still largely unknown.
Family, twin, and adoption studies consistently found that BPD is highly heritable, estimated at up to 85% [3] [4] [5] .
Moreover, there are substantial interactions between genetic and environmental factors [5] .
The monoamine hypothesis, which mainly concerns the three classic neurotransmitters serotonin, noradrenalin, and dopamine, includes the concept that disruption of serotonergic function is involved in the pathogenesis of many psychiatric disorders, such as BPD, major depression disorder, and schizophrenia [6, 7] . Serotonin (5-hydroxytryptamine, 5-HT) influences a broad range of behavioral functions, including the control of mood, the sleep-wake cycle, appetite, sexual behavior and cognition [8] [9] [10] .
Serotonin homeostasis is mainly modulated at pertinent targets such as receptors, transporter, and enzymes in its biosynthetic pathway. Tryptophan hydroxylase 2 (TPH2), [11] . Recent studies have provided some evidence for the involvement of the TPH2 gene in BPD and major depression disorder [12] [13] [14] [15] [16] [17] . The HTR2A gene encodes one of the neurotransmitter receptors for serotonin, and may alter the levels of serotonin metabolites. Increased levels of 5-HT2 receptors have been associated with mood disorders and sleep disturbances [18] [19] [20] [21] . Postmortem studies on people with depression have shown changes in 5-HT2A
receptors in different brain regions, which implicate it in mood regulation [22] [23] [24] . In addition, a genome-wide linkage study of a large multigenerational BPD pedigree identifi ed a susceptibility locus on chromosome 13q where the HTR2A gene is located [25] , with subsequent replication in 13
Australian BPD pedigrees [26] . Large association studies [27] [28] [29] , meta-analysis [30] , and convergent functional genomics also support the involvement of HTR2A in BPD [31] . The human 5-HT transporter (5-HTT) is encoded by the serotonin transporter gene (SLC6A4) on 17q11.2-12 [32] , and is responsible for terminating the action of 5-HT in the synaptic cleft [33] . Low levels of platelet and brain 5-HTTs have been reported to be associated with depression and suicide [34] [35] [36] . However, previous studies of the possible involvement of SLC6A4 in BPD have produced confl icting results [37] [38] [39] [40] [41] .
In the current study, we investigated in a Han Chinese population the involvement of TPH2, HTR2A and SLC6A4 in serotonin pathway in the development of BPD, using a case-control association design. Only patients with bipolar I disorder (BP-I) who had more than one manic episode were included in order to reduce the phenotypic heterogeneity due to various clinical manifestations.
PARTICIPANTS AND METHODS

Samples
Patients in the BP-I group: 375 in-patients or out-patients at the Guangzhou Brain Hospital were included in the study. All patients were interviewed individually by trained psychiatrists using the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) Axis I Disorders [42] . 
Genotyping
Peripheral blood (5 mL) was collected from all participants, and genomic DNA was extracted according to the standard phenol-chloroform procedure [43] . that occurred with a frequency of <5% in controls were excluded). Bonferroni correction was used to reduce falsepositives due to multiple tests [45] .
Statistical Analysis
RESULTS
Demographic Characteristics
Sex and age distribution did not differ signifi cantly between patients with BP-I and normal controls, but there was a significant difference in years of education. The age at onset in patients with BP-I was 24.3 ± 8.9 years (mean ± SD) ( Table 1) .
Hardy-Weinberg Equilibrium Test
The genotypic frequencies of 52 SNPs within the TPH2, HTR2A, and SLC6A4 genes were in Hardy-Weinberg disequilibrium in the control group (P >0.05 for all SNPs). 
Effects of multi-marker haplotypes
The aim of multiplemarker analysis is to find haplotypes with significant associations that can be used to map true susceptibility in the region. Consequently, only those haplotypes with a global P value of <0.05, and at least one specific haplotype with a corrected P value of <0.05 are shown (Table 3) . We found that haplotypes with multiple-markers (SNPs rs1928038 -rs1475196 -rs9562689 -rs9567747 -rs1328684 -rs1328684) showed significant association with BPD-I, with a global P value of 0.003, and three specific haplotypes (CAAGAA, GAGGAA, and CCGAAA)
with corrected P values of <0.05.
DISCUSSION
In the present study, we found that 2 out of 21 SNPs (rs1475196 and rs9567747) in the HTR2A gene and 1 out of 23 SNPs (rs17110566) in the TPH2 gene were signifi cantly Furthermore, a specifi c haplotype within the HTR2A gene also showed significant association with the disease by multi-marker haplotype analysis. The combined evidence from the current study supports the hypothesis that genes in the serotonin pathway, especially the HTR2A and TPH2
genes, play important roles in susceptibility to BP-I.
The TPH2 gene is located on chromosome 12q21.1, spanning ~93 kb and containing 12 exons [11, 46] . This gene encodes a member of the pterin-dependent aromaticacid hydroxylase family and plays an important role in the regulation of serotonin function [46] . Many previous studies suggested that this chromosome region might be associated with BPD. For example, significant linkage between BPD and chromosome 12q23-24 has been reported in a number of independent linkage analyses [47] [48] [49] .
Cichon et al. found a significant association between rs17110563 in the TPH2 gene, which encodes a Pro206Ser substitution, and BPD [50] . Zhang et al. reported that a rare loss-of-function mutation (G1463A) in the TPH2 gene may represent an important risk factor for unipolar major depression [14] . Lopez et al. found that the haplotype G-T-A (rs1386494 -rs1007023 -rs9325202), located in the HTR2A gene, contributes to the risk of both BPD and suicide attempts in families with BPD [17] . Another report indicated that the C2755A polymorphism, which leads gene expression [51] . In the current study, the associated SNP (rs17110566) in an intron region of the TPH2 gene is unlikely to affect the coding sequence of TPH2, but it may be involved in BP-I by LD or by influencing TPH2 mRNA expression. Taking into account the possible strong LD between rs17110566 and nearby variants, the causal variants may be harbored in the haplotype block we identified. As Cichon et al. suggested , further studies should be focused on detecting low-frequency and highfrequency penetrance variants in order to identify the full spectrum of susceptibility variants present in the haplotype blocks in the TPH2 gene [50] .
Studies on the HTR2A gene have also produced controversial results. Some previous studies suggested that this gene is associated with BPD [52] [53] [54] [55] , but others did not support these fi ndings [56] [57] [58] . A recent Australian cohort study selected eight SNPs across the HTR2A gene and found that two common variants (rs2224721 and rs1923886) and a haplotype block (CCGCA) are associated with BPD [55] . In our study, we did not fi nd signifi cant association between these two common variants (rs2224721 and rs1923886) near the 5'UTR and BP-I. However, two other common variants (rs1475196 and rs9567747) near the UTR of the The inconsistency between Australian cohort study and ours may be due to genetic heterogeneity in the different populations. Alternatively, false-positives may have been produced in either or both studies due to phenotypic heterogeneity. In order to reduce this heterogeneity, [38, 41, 59, 60] , although confl icting results have also been reported [61, 62] . A study of [39] . Our fi ndings did not show any statistical significance for either individual SNPs or haplotype analysis, providing no evidence for the SLC6A4 gene as a susceptibility gene of BPD-I.
Although many studies have shown associations between genes in the serotonin pathway and BPD, they mainly focused on several functional polymorphisms within these genes [14, 39, 50, 53] . There are two advantages in current study. First, we selected tagger SNPs throughout the candidate gene to investigate the association. Furthermore, only patients with BP-I were included in order to reduce phenotypic heterogeneity.
Previous studies showed that patients with BPD have better academic performance than controls [63] [64] [65] .
This is partly in line with our finding that individuals with BP-I had a higher education level, probably due to their better academic ability. It has been suggested that genetic factors contribute to better academic performance as well as susceptibility to illness in patients with BPD [63, [66] [67] [68] .
However, other studies have reported lower premorbid IQ scores or poorer school performance in such patients [64, [69] [70] [71] .
It is worth exploring whether education level contributes to the susceptibility to BPD as an environmental factor; this would need a longitudinal study with sophisticated design.
Considering the small effect size of susceptibility genes for complex genetic disorders such as BPD, the sample sizes of 375 patients with BP-I and 475 controls in this study were still relatively small. Type II errors, through the lack of an observed association between the analyzed polymorphism and BP-I, cannot be ruled out. Ethnic differences should also be considered in explaining the results, as most previous studies were performed in other populations such as Caucasians [55] . Further analysis with a larger and independent sample is warranted. Another limitation of this study is that we performed the association analysis between genes in the serotonin pathway and BP-I only. In the future, it will also be important to explore the contribution of genes in the serotonin pathway (e.g. 
